MAJOR — Use With Caution
FDA-documented interaction. Sometimes prescribed together intentionally (mechanical valve + stent) but bleeding risk is very high. Triple therapy (warfarin + clopidogrel + aspirin) is extremely high risk.
Evidence level: STRONG
Taking both warfarin (a blood thinner) and clopidogrel (Plavix, an antiplatelet) together dramatically increases your risk of serious bleeding because they prevent blood clotting through different mechanisms.
Dual antithrombotic: warfarin inhibits coagulation factors, clopidogrel inhibits platelet aggregation via P2Y12 receptor. Combined use dramatically increases bleeding risk. FDA labels warn about combination.
If prescribed both, there is likely a specific medical reason (such as a heart stent while on warfarin for another condition). Your bleeding risk is very high — report any bleeding immediately. Avoid NSAIDs and alcohol.
Dual anticoagulation carries high bleeding risk and requires specialist supervision. Take each at exactly the prescribed times. Report any unusual bleeding (bruising, dark stools, blood in urine, prolonged cuts) immediately. Keep emergency contact information accessible.
Higher risk for: elderly patients, those with liver disease, history of GI bleeding, concurrent use of multiple blood thinners, recent surgery, vitamin K intake changes, alcohol use, or low body weight.
Any unusual bleeding: bruising, blood in urine/stool, nosebleeds, prolonged bleeding from cuts, black stools, vomiting blood
Discuss duration of dual therapy. Request gastroprotection with PPI. Target lower INR range. Consider DOAC switch if appropriate. Triple therapy should be limited to shortest necessary duration.
This medication combination requires careful medical oversight. Your doctor or anticoagulation clinic can adjust doses or select alternatives with fewer bleeding risks. Frequent INR monitoring is essential.
Taking both warfarin (a blood thinner) and clopidogrel (Plavix, an antiplatelet) together dramatically increases your risk of serious bleeding because they prevent blood clotting through different mechanisms.
Dual anticoagulation carries high bleeding risk and requires specialist supervision. Take each at exactly the prescribed times. Report any unusual bleeding (bruising, dark stools, blood in urine, prolonged cuts) immediately. Keep emergency contact information accessible.
Any unusual bleeding: bruising, blood in urine/stool, nosebleeds, prolonged bleeding from cuts, black stools, vomiting blood
This medication combination requires careful medical oversight. Your doctor or anticoagulation clinic can adjust doses or select alternatives with fewer bleeding risks. Frequent INR monitoring is essential.
Discuss duration of dual therapy. Request gastroprotection with PPI. Target lower INR range. Consider DOAC switch if appropriate. Triple therapy should be limited to shortest necessary duration.
Or browse the full interaction database (121,000+ pairs).